News & Media
Australian lung fibrosis patient on long kayak to call for better treatments
AdAlta’s i-body platform: reaching for the high-hanging fruit
Wrap Up: CEO Sam Cobb attends 121 Tech Investment in Hong Kong
Smaller, smarter antibody-like drugs: An update report from NDF Research
CEO Sam Cobb profiled by Fairfax Media ‘Watch out CSL, here we come’